A Double-blind Study of Paclitaxel in Combination With Reparixin or Placebo for Metastatic Triple-Negative Breast Cancer
Clinical trial NCT02370238 · COMPLETED
Trial details
- NCT number
- NCT02370238
- Sponsor
- Dompé Farmaceutici S.p.A
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-29
- Primary completion
- 2019-02-20
- Enrollment
- 194
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.